Yahoo · Oct 1, 2026
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A
NASDAQ · A
Agilent Technologies, Inc.
Healthcare · Medical - Diagnostics & Research
$170.54
Up+$2.37 (+1.41%)
Updated Oct 10, 2026, 8:20 PM
SID Score
7.2/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 34.41B
- P/E ratio
- 26.63
- Dividend yield
- 0.73%
- 52-week range
- $108.35 – $177.05
- Volume
- 1.54M
- Avg. volume
- 2.17M
Price performance · A
A price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
A closed at $170.54 after 21 trading sessions, up 16.07% for the selected period.
- Last close
- $170.54
- Period change
- +16.07%
- Period low
- $146.80
- Period high
- $175.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $168.57 | $172.19 | $168.57 | $170.54 | 1.54M |
| Oct 8, 2026 | $167.48 | $168.66 | $163.32 | $168.17 | 2.72M |
| Oct 7, 2026 | $169.88 | $171.27 | $166.52 | $169.09 | 2.56M |
| Oct 6, 2026 | $172.77 | $176.38 | $168.01 | $169.33 | 1.87M |
| Oct 5, 2026 | $167.35 | $171.425 | $166.49 | $171.29 | 1.77M |
| Oct 2, 2026 | $168.25 | $170.24 | $166.33 | $167.78 | 2.29M |
| Oct 1, 2026 | $172.00 | $172.57 | $166.07 | $166.68 | 2.79M |
| Sep 30, 2026 | $174.44 | $176.04 | $172.27 | $172.31 | 2.59M |
| Sep 29, 2026 | $174.49 | $177.05 | $173.22 | $175.03 | 2.05M |
| Sep 28, 2026 | $170.00 | $176.0228 | $169.50 | $175.21 | 2.19M |
| Sep 25, 2026 | $171.98 | $172.94 | $169.43 | $172.79 | 2.58M |
| Sep 24, 2026 | $163.95 | $174.77 | $163.62 | $172.84 | 3.05M |
| Sep 23, 2026 | $166.54 | $168.94 | $163.27 | $165.32 | 3.24M |
| Sep 22, 2026 | $163.08 | $167.59 | $161.035 | $167.26 | 3.78M |
| Sep 21, 2026 | $157.87 | $162.89 | $157.08 | $161.94 | 2.71M |
| Sep 18, 2026 | $156.00 | $156.73 | $154.60 | $156.47 | 4.85M |
| Sep 17, 2026 | $156.00 | $156.89 | $154.03 | $156.34 | 2.89M |
| Sep 16, 2026 | $150.83 | $155.52 | $150.30 | $153.69 | 2.51M |
| Sep 15, 2026 | $147.00 | $150.96 | $147.00 | $150.27 | 1.68M |
| Sep 14, 2026 | $148.00 | $148.50 | $144.65 | $146.80 | 1.65M |
| Sep 11, 2026 | $144.48 | $146.975 | $143.18 | $146.93 | 1.78M |
Latest A news
The latest Smart Investors Daily articles mentioning A.
Stock researchCompany · Overview
Company
Market Activity
Research & News
A research
Overview
Company profile and research snapshot.
Company profile
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $165.56
- Implied upside
- —
- Analysts
- 26
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 7, 2026 | Barclays | Overweight | — |
| Aug 27, 2026 | Bernstein | Outperform | — |
| Aug 27, 2026 | TD Cowen | Buy | — |
| Aug 27, 2026 | JP Morgan | Overweight | — |
| Aug 27, 2026 | Goldman Sachs | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Oct 1, 2026
$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today
Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization
Yahoo · Oct 1, 2026
Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows
SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time
Yahoo · Sep 29, 2026
Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers
SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
